Circle, a leading fintech company, has announced a significant milestone in its growth journey by securing an impressive funding of $250 million. This investment will be pivotal in further accelerating Circle's mission to revolutionize the way businesses and individuals participate in the digital economy. The funding will fuel the expansion of Circle's innovative products and services, enabling them to continue providing cutting-edge solutions that simplify financial transactions and promote seamless global connectivity. With this substantial investment, Circle is poised to strengthen its position as a key player in the rapidly evolving fintech landscape and establish itself as a driving force in shaping the future of finance.
Crypto Giant Circle Raises $250 Million in Latest Funding Round
Recently funded 路 $250.0MAdvertising Services
Get the full Circle company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
